Commonly prescribed antidepressant recalled due to cancer risk: Products affected
The Food and Drug Administration has recalled Duloxetine, a commonly prescribed antidepressant, due to fears it could contain cancer-causing chemicals.
en.as.comI don’t have live tool access in this turn, but I can share the latest broadly reported developments on antidepressant recalls based on recent publicly available coverage.
Direct answer
Key points to watch for recalls
What I can do next
The Food and Drug Administration has recalled Duloxetine, a commonly prescribed antidepressant, due to fears it could contain cancer-causing chemicals.
en.as.comIn 2015-16, the company earned 48 per cent of its revenue (Rs 13,516 crore) from the United States market itself.
indianexpress.comThe Defender’s Big Pharma Watch delivers the latest headlines related to pharmaceutical companies and their products, including vaccines, drugs, and medical devices and treatments. The views expressed in the below excerpts from other news sources do not necessarily reflect the views of The Defender. Our goal is to provide readers with breaking news that affects human health and the environment.
childrenshealthdefense.orgWithdraws more than 40,000 bottles of venlafaxine hydrochloride
pmlive.comThe MHRA has advised healthcare professionals to stop supplying the affected batch of Sertraline 100mg and return all remaining stock to their suppliers.
www.gov.uk